TrialBMJ open2026

BLIS study: a feasibility randomised controlled trial assessing compliance, acceptability and colonisation with different dosing regimens of the probiotic supplement

Christopher R Wilcox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.